Geneva continues to hold the top spot as the world's most expensive city for construction, leading a ranking of 100 global markets. According to the 2026 International Construction Cost Index from Arcadis, the premium on building in mature cities reflects a shift toward prioritizing delivery certainty over raw price.
A two-year study involving 1,065 older adults across 11 Latin American countries confirms that culturally adapted lifestyle programs significantly improve cognitive function. The findings, presented at the Alzheimer’s Association International Conference, reveal that structured coaching and peer support outperform self-guided approaches in reducing dementia risk among diverse populations.
A new $100 million global clinical trial is set to determine if pairing intensive lifestyle interventions with metabolism-targeting drugs can stall cognitive decline. Announced at the Alzheimer's Association International Conference in London, the PROTECT-Cog study seeks to build on earlier research by testing the combined effects of biology and behavior.
Two decades after the Yinxu Ruins in Anyang were inscribed on the UNESCO World Heritage list, the site has evolved from a scholarly focal point into a cultural touchstone. Today, visitors encounter the Shang Dynasty through everything from oracle bone research to playful, owl-inspired merchandise, bridging a 3,300-year historical divide.
Data presented at the 2026 Alzheimer's Association International Conference in London confirms that the subcutaneous autoinjector formulation of Leqembi provides comparable efficacy and safety to traditional intravenous administration. The findings suggest a potential shift toward more flexible, at-home treatment pathways for patients living with early-stage Alzheimer's disease.
Patients with early-stage Alzheimer’s may soon have a more flexible treatment option, as new clinical data suggests a subcutaneous autoinjector for Leqembi matches the efficacy and safety of traditional intravenous infusions. The findings, presented at the 2026 Alzheimer’s Association International Conference in London, could simplify long-term disease management.
Antengene Corporation has received a $60 million upfront payment from UCB, marking a significant milestone in their March 2026 global licensing agreement. The deal grants UCB exclusive rights to develop and commercialize ATG-201, a bispecific T-cell engager antibody designed to target B cell-driven autoimmune diseases.
Tokyo-based VoicePing Inc. has launched version 3.0 of its AI-driven platform, aiming to integrate real-time translation, automated meeting minutes, and enterprise-grade security into a single workflow for distributed global teams. The update addresses the fragmentation of communication across hybrid offices, web conferences, and recorded media.
At the Intersolar Europe 2026 exhibition in Munich, Sungrow and TÜV Rheinland unveiled the industry’s first quantitative reliability standards for photovoltaic inverters. By bridging the gap between laboratory testing and field performance, the framework aims to ensure equipment durability over a 25-year operational lifespan in extreme environments.
Investors who purchased common stock in Erasca, Inc. between January 14, 2025, and April 26, 2026, have until August 10, 2026, to file as lead plaintiffs in a pending securities class action. The lawsuit alleges that the company misled shareholders regarding the clinical prospects of its lead oncology candidate, ERAS-0015.
A Brussels public prosecutor’s move to summon Wise Group plc before a criminal court has triggered a securities class action investigation. The probe follows reports that the payment processor potentially misled investors regarding its business practices, leading the New York-based Rosen Law Firm to seek compensation for those holding WSE stock.
Three months after their initial agreement, Insilico Medicine and China Medical System Holdings have launched a new joint R&D program targeting central nervous system disorders. The partnership utilizes Insilico’s PandaOmics platform to identify novel mechanisms of action for mass-market therapeutic candidates, with potential milestone payments reaching 1.2 billion RMB.
Investors who purchased Badger Meter, Inc. common stock between April 18, 2024, and April 16, 2026, face an August 3, 2026, deadline to seek the role of lead plaintiff. The ongoing class action alleges the company misled shareholders regarding the true drivers of its reported financial growth.
The Rosen Law Firm has launched an investigation into potential breaches of fiduciary duties by directors and officers at Manhattan Associates, Inc. The New York-based firm is currently soliciting inquiries from shareholders of the NASDAQ-listed company to determine if legal action is warranted regarding corporate governance failures.
Investors who purchased GeneDx Holdings Corp. common stock between April 16, 2025, and May 4, 2026, have until August 3, 2026, to file for lead plaintiff status. A class action lawsuit alleges that the company misled shareholders regarding the financial benefits and operational viability of its acquisition of Fabric.
Investors who purchased ADMA Biologics, Inc. securities between August 9, 2024, and March 25, 2026, have until August 10, 2026, to apply for lead plaintiff status in a pending class action lawsuit. The litigation, initiated by The Rosen Law Firm, alleges the company misled shareholders regarding its financial health and internal controls.
As CHAI AI awaits approval for its latest app update from Apple, CEO William Beauchamp is positioning the platform—now generating $100 million in annual revenue—as a safer, more robust environment. The Palo Alto-based firm is banking on a new governance system to manage its millions of daily users.
Investors who purchased Photronics, Inc. securities between December 10, 2025, and May 27, 2026, are being urged to join a class action lawsuit filed by the Rosen Law Firm. Those seeking to serve as lead plaintiff in the case must submit their motion to the court by September 4, 2026.
Investors who held Sportradar Group AG shares between November 2024 and April 2026 have until July 17 to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s regulatory compliance and its purported dealings with black-market gambling operators.
PMET Resources has achieved a recovery rate exceeding 97% in initial bench-scale tests to extract caesium from pollucite concentrate. Conducted at SGS Canada’s Lakefield facility, the program utilized sulphuric acid leaching to process material from the company’s Shaakichiuwaanaan Project in Quebec, marking a milestone in potential value-added chemical production.
A study of 141 Medicare patients reveals that remote cognitive rehabilitation delivered via telephone achieves outcomes equal to or better than traditional outpatient care. By removing the need for smartphones or internet access, the program provides a viable pathway to treatment for patients living in underserved neurology deserts.
Bridesmaid shopping moves from the screen to the fitting room as Azazie arrives in San Diego for a singular, day-long event. On July 12, the brand transforms the Liberty Ballroom at the Courtyard San Diego Airport into an interactive showroom for bridal parties to test fabrics, fits, and color palettes in person.
Jordan Williams claimed his second consecutive Elite Men's Downhill victory at Pal Arinsal, navigating the grueling Andorran course to finish over two seconds ahead of the field. The 21-year-old Briton’s dominant performance marks his third career World Cup win, effectively reshaping the leaderboard as the 2026 series reaches its midway point.
Investors who purchased AeroVironment, Inc. securities between June 25, 2025, and March 10, 2026, have until July 27, 2026, to file for lead plaintiff status. The class action lawsuit, filed in the Eastern District of Virginia, alleges the company misled shareholders regarding its competitive standing in a key U.S. Space Force contract.
The largest nurse strike and lockout in Massachusetts history concludes Monday at 6:59 a.m. as Brigham and Women’s Hospital staff participate in a solidarity walk-in. Meanwhile, MGB Home Care clinicians remain on the picket line until Tuesday, when they plan to gather at the system's headquarters to mark their own strike's conclusion.
Investors who purchased Megan Holdings Limited shares between September 26, 2025, and March 25, 2026, are now the focus of a class action lawsuit. Filed by Bronstein, Gewirtz & Grossman, the complaint accuses the firm of misleading shareholders about market manipulation schemes and severe internal accounting failures.
Glioblastoma remains one of the most lethal forms of brain cancer, with survival rates rarely exceeding 15 months and few treatment breakthroughs in decades. Seattle-based HDT Bio is now launching a Canadian clinical program in partnership with McGill University to test an investigational immune activator, HDT-401.
Drawing inspiration from the American Southwest and its own 1980s heritage, Jeep has unveiled the 2027 Wrangler Laredo. As the ninth entry in the brand's Twelve 4 Twelve series, the model transitions from an Easter Jeep Safari concept to a production vehicle, blending classic western aesthetics with the rugged Xtreme 35 hardware.
New clinical data presented at the Alzheimer's Association International Conference in London suggests that a subcutaneous autoinjector version of LEQEMBI provides comparable efficacy and safety to the current intravenous formulation, potentially offering patients a more convenient at-home treatment option for early-stage Alzheimer's disease.
As biological collagen production naturally wanes with age, consumers are increasingly turning toward peptide-based supplementation to address systemic structural decline. PureHealth Research is positioning its focus on Morikol® Marine Collagen Tripeptides, citing the ingredient's bioavailability as a primary driver for those seeking to bolster joint mobility, skin elasticity, and hair strength.
